These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 9192249)

  • 1. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
    Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H
    Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Combination effect of teicoplanin and panipenem on highly resistant strains of MRSA].
    Utsui Y; Ishii C; Abe T; Kakuta M; Ohya S
    Jpn J Antibiot; 1999 Mar; 52(3):268-77. PubMed ID: 10367264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro antibacterial activity of vancomycin in combination with panipenem against carbapenem-resistant MRSA].
    Sato S; Miura T; Kudo Y; Kudo E; Saitoh Y; Kimpara I; Tsujino M; Kudo H
    Jpn J Antibiot; 1998 Jul; 51(7):488-93. PubMed ID: 9755432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
    Sato S; Miura T; Kudo E; Kudo Y; Saitoh Y; Kimpara I; Tsujino M; Kudo H
    Jpn J Antibiot; 1997 Aug; 50(8):711-6. PubMed ID: 9339397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of panipenem and aminoglycosides on methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa in vitro.
    Katou K; Nakamura A; Kato T; Tonegawa K; Kutsuna T; Niwa T; Morita H; Itoh M
    Chemotherapy; 2005 Oct; 51(6):387-91. PubMed ID: 16227698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
    Araake M; Hara T; Miyata A; Tani M; Ogawa H
    Jpn J Antibiot; 2001 Feb; 54(2):69-78. PubMed ID: 11338680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent activity of FK037, a novel parenteral broad-spectrum cephalosporin, against methicillin-resistant staphylococci.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Kuno K; Kamimura T; Tawara S; Matsumoto Y; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):99-119. PubMed ID: 8436564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activities of novel trans-3,5-disubstituted pyrrolidinylthio-1beta-methylcarbapenems with potent activities against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa.
    Nagano R; Shibata K; Adachi Y; Imamura H; Hashizume T; Morishima H
    Antimicrob Agents Chemother; 2000 Mar; 44(3):489-95. PubMed ID: 10681308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methicillin-resistant Staphylococcus aureus: comparison of susceptibility testing methods and analysis of mecA-positive susceptible strains.
    Sakoulas G; Gold HS; Venkataraman L; DeGirolami PC; Eliopoulos GM; Qian Q
    J Clin Microbiol; 2001 Nov; 39(11):3946-51. PubMed ID: 11682512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of combination of oxacillin and non-beta-lactam antibiotics on methicillin-resistant Staphylococcus aureus.
    Komatsuzawa H; Suzuki J; Sugai M; Miyake Y; Suginaka H
    J Antimicrob Chemother; 1994 Jun; 33(6):1155-63. PubMed ID: 7928809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro combined effects of cefozopran/teicoplanin and cefozopran/vancomycin on methicillin-resistant Staphylococcus aureus.
    Toyokawa M; Asari S; Nishi I; Horikawa M; Tsukamoto H; Sunada A; Ueda A; Iwatani Y
    J Chemother; 2003 Feb; 15(1):31-6. PubMed ID: 12678411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
    Sumita Y; Nouda H; Kanazawa K; Fukasawa M
    Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
    Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
    Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
    Ishii T; Takayama Y; Takase Y; Orikasa Y
    Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins.
    Piddock LJ; Traynor EA; Wise R
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():59-64. PubMed ID: 2732144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activities of a novel cephalosporin, BMS-247243, against methicillin-resistant and -susceptible staphylococci.
    Fung-Tomc JC; Clark J; Minassian B; Pucci M; Tsai YH; Gradelski E; Lamb L; Medina I; Huczko E; Kolek B; Chaniewski S; Ferraro C; Washo T; Bonner DP
    Antimicrob Agents Chemother; 2002 Apr; 46(4):971-6. PubMed ID: 11897577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibacterial activity of cefmetazole alone and in combination with fosfomycin against methicillin- and cephem-resistant Staphylococcus aureus.
    Utsui Y; Ohya S; Magaribuchi T; Tajima M; Yokota T
    Antimicrob Agents Chemother; 1986 Dec; 30(6):917-22. PubMed ID: 3468883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro combination effect of pazufloxacin with various antibiotics against Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus].
    Maekawa M; Takahashi K; Takahata M; Minami S
    Jpn J Antibiot; 2002 Aug; 55(4):440-5. PubMed ID: 12378872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
    Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
    J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.